Navigating The Deuteration Landscape: Innovations, Challenges, and Clinical Potential of Deuterioindoles
ChemBioChem · 2025
DOI: 10.1002/cbic.202400837 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, 2025. Verfasst von Li Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy and College of Medical Technology, Chengdu University of Traditio…. Hauptthemen laut MEDLINE: Indoles, Deuterium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Sichuan Science and Technology Innovation Talent Project.
Abstract (Originalsprache)
Indoles, pivotal to the realm of drug discovery, underpin numerous FDA‐approved therapeutics. Despite their clinical benefits, pharmacokinetic and toxicity concerns have occasionally hampered their broader application. A notable advancement in this domain is the substitution of hydrogen atoms with deuterium, known as deuterium modification, which significantly enhances the pharmacological properties of these compounds. This review elucidates the progression of deuterium chemistry, culminating in approval of Deutetrabenazine in 2017. This milestone has catalyzed additional research into deuterated indoles, such as Dosimertinib, which have demonstrated enhancements in stability, toxicity profiles, and therapeutic efficacy. Moreover, the review addresses challenges and patent issues in the synthesis of deuterated indoles and highlights their potential applications in precision medicine. In the future, deuterated indoles may positively impact therapy and contribute to advances in precision medicine through molecular engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy and College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
ORCID-Profile: Bo Han
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Sichuan Science and Technology Innovation Talent Project
- Postdoctoral Research Project of Sichuan Province
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- Xinglin Scholar Research Promotion Project of Chengdu University of TCM
Zitieren
APA
Zhang, L., Zhang, S., Zhang, Y., Liu, B., Li, X., & Han, B. (2025). Navigating The Deuteration Landscape: Innovations, Challenges, and Clinical Potential of Deuterioindoles. ChemBioChem. https://doi.org/10.1002/cbic.202400837
Vancouver
Zhang L, Zhang S, Zhang Y, Liu B, Li X, Han B. Navigating The Deuteration Landscape: Innovations, Challenges, and Clinical Potential of Deuterioindoles. ChemBioChem. 2025. doi:10.1002/cbic.202400837
BibTeX
@article{Zhang2025,
author = {Zhang, Li and Zhang, Shujingwei and Zhang, Yang and Liu, Bo and Li, Xiang and Han, Bo},
title = {Navigating The Deuteration Landscape: Innovations, Challenges, and Clinical Potential of Deuterioindoles},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202400837}
}
EUVIMED